Hormonal
Testosterone administration is absolutely contraindicated in men with clinical (metastatic) prostate cancer because androgen supplementation promotes tumor growth and progression.
If you have been diagnosed with metastatic prostate cancer, you must NOT take testosterone replacement therapy. It will cause your cancer to grow and spread. The standard treatment is to lower testosterone levels (androgen ablation).
Therefore, testosterone administration is absolutely contraindicated in men with a clinical prostate cancer... a study (Fowler and Whitmore 1981) of patients with metastatic prostate cancer documented tumor progression in 33 of 34 patients who received testosterone supplementation
Why this rating
Based on historical clinical observations of tumor regression with castration and progression with androgen supplementation.
Source
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
Shalender Bhasin et al. · Journal of Andrology · 2003
DOI 10.1002/j.1939-4640.2003.tb02676.x
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →